Pages that link to "Q33919973"
Jump to navigation
Jump to search
The following pages link to Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin (Q33919973):
Displaying 50 items.
- Tuberculosis vaccines: beyond bacille Calmette-Guerin (Q22242669) (← links)
- Future Vaccination Strategies against Tuberculosis: Thinking outside the Box (Q22252427) (← links)
- A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers (Q24657992) (← links)
- Innate Immunity Holding the Flanks until Reinforced by Adaptive Immunity against Mycobacterium tuberculosis Infection (Q26751060) (← links)
- Tuberculosis vaccines and prevention of infection (Q26782022) (← links)
- Recent advances in the diagnosis and treatment of childhood tuberculosis (Q26797426) (← links)
- Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy (Q26798372) (← links)
- Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis (Q26824812) (← links)
- Vaccine development for tuberculosis: current progress (Q26827737) (← links)
- Mycobacterium tuberculosis: success through dormancy (Q26852023) (← links)
- Interaction of Mycobacterium tuberculosis with host cell death pathways (Q26852548) (← links)
- Recent advances towards tuberculosis control: vaccines and biomarkers (Q26859739) (← links)
- Tuberculosis vaccine types and timings (Q26862762) (← links)
- Vaccines against tuberculosis: where are we and where do we need to go? (Q26992233) (← links)
- Vaccines for TB: Lessons from the Past Translating into Future Potentials (Q26996673) (← links)
- Prime-boost approaches to tuberculosis vaccine development (Q27024526) (← links)
- Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker? (Q28083050) (← links)
- Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? (Q28083377) (← links)
- Mycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human Tuberculosis (Q28083909) (← links)
- Current efforts and future prospects in the development of live mycobacteria as vaccines (Q28087077) (← links)
- Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy (Q28354371) (← links)
- A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data (Q28383049) (← links)
- Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells (Q28469257) (← links)
- Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis (Q28476716) (← links)
- Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells (Q28543248) (← links)
- A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren (Q28551001) (← links)
- Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis (Q28730427) (← links)
- Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells (Q28730854) (← links)
- Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination. (Q30227028) (← links)
- Evaluation of new vaccines for tuberculosis in the guinea pig model (Q30227505) (← links)
- Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. (Q30361227) (← links)
- Novel vaccination strategies against tuberculosis. (Q30363188) (← links)
- Recombinant Mycobacterium bovis BCG as an HIV vaccine vector (Q30387447) (← links)
- Toward novel vaccines against tuberculosis: current hopes and obstacles. (Q30484783) (← links)
- Fidelity of pathogen-specific CD4+ T cells to the Th1 lineage is controlled by exogenous cytokines, interferon-gamma expression, and pathogen lifestyle. (Q30496153) (← links)
- rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector (Q33386020) (← links)
- Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung (Q33389187) (← links)
- Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages (Q33526364) (← links)
- Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains (Q33527616) (← links)
- Polyclonal activation of naïve T cells by urease deficient-recombinant BCG that produced protein complex composed of heat shock protein 70, CysO and major membrane protein-II (Q33573078) (← links)
- Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice (Q33724934) (← links)
- Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection (Q33737428) (← links)
- Strains of the East Asian (W/Beijing) lineage of Mycobacterium tuberculosis are DosS/DosT-DosR two-component regulatory system natural mutants (Q33769184) (← links)
- The immunology of tuberculosis: from bench to bedside (Q33777367) (← links)
- Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial (Q33793948) (← links)
- Screening of Mycobacterium avium subsp. paratuberculosis mutants for attenuation in a bovine monocyte-derived macrophage model (Q33822293) (← links)
- Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques (Q33877458) (← links)
- Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model (Q33933553) (← links)
- The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigen (Q33952259) (← links)
- Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice. (Q34053027) (← links)